Topic search: FORMULATIONS

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Refine your search by entering keywords here:

Formulation Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2025 Pg. 291-292	Calculations: Polyox Bandage for Skin Ulcers Formula Calculations Author(s): Stockton Shelly J
Jul/Aug 2025 Pg. 293	Clonidine Hydrochloride 0.1 mg/mL Oral Liquid Author(s):
Jul/Aug 2025 Pg. 294-295	Dexamethasone 1-mg/mL Oral Suspension Author(s):
Jul/Aug 2025 Pg. 296-297	Metformin Hydrochloride 100-mg/mL Oral Suspension Author(s):
Jul/Aug 2025 Pg. 298	Methadone Hydrochloride 0.33-mg/mL Oral Solution Author(s):
Jul/Aug 2025 Pg. 299	Ranitidine Hydrochloride 15-mg/mL Oral Liquid Author(s):
May/Jun 2025 Pg. 202-203	Calculations - Caspofungin Acetate Injection for Reconstitution and Dextrose 5% with Electrolyte No. 48 Infusion Author(s): Stockton Shelly J
May/Jun 2025 Pg. 204	Benzoyl Peroxide 10% Gel Author(s):
May/Jun 2025 Pg. 205	Diclofenac Sodium 1% Topical Gel Author(s):
May/Jun 2025 Pg. 206	Ketorolac Tromethamine 2% Topical Gel Author(s):
May/Jun 2025 Pg. 207	Medicated Polyox Bandage for Skin Ulcers Author(s):
May/Jun 2025 Pg. 208	Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Author(s):
May/Jun 2025 Pg. 210-221	Formulation and Optimization of Novel Antiaging Polyherbal Liposal Gel Using Central Composite Design Author(s): Amalu Mathew, Roshita Mariate B, Honeymol George, J Tina, Gifty Jojo M
Mar/Apr 2025 Pg. 122	Atropine Sulfate 1% Ophthalmic Solution Author(s):
Mar/Apr 2025 Pg. 123-124	Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Gel Author(s):
Mar/Apr 2025 Pg. 125	Chlorothiazide 50-mg/mL Oral Suspension Author(s):
Mar/Apr 2025 Pg. 126	Folic Acid 1-mg/mL Oral Liquid Author(s):
Mar/Apr 2025 Pg. 127	Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide-Magnesium Hydroxide-Simethicone Mouthwashes Author(s):
Mar/Apr 2025 Pg. 128	Tetracaine Hydrochloride 2% Topical Solution Author(s):
Mar/Apr 2025 Pg. 129	Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution Author(s):
Mar/Apr 2025 Pg. 130	Topiramate 6-mg/mL Oral Suspension Author(s):
Mar/Apr 2025 Pg. 131	Vancomycin 31-mg/mL Ophthalmic Solution Author(s):
Jan/Feb 2025 Pg. 42	Allopurinol 20-mg/mL Oral Suspension Author(s):
Jan/Feb 2025 Pg. 43-44	Chloral Hydrate 25-mg/mL Oral Suspension Author(s):
Jan/Feb 2025 Pg. 45	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s):
Jan/Feb 2025 Pg. 46	Lansoprazole 3-mg/mL Oral Suspension Author(s):
Jan/Feb 2025 Pg. 47	Levothyroxine Sodium 40-ug/mL Oral Liquid Author(s):
Jan/Feb 2025 Pg. 48	Nifedipine 0.5% Rectal Ointment Author(s):
Jan/Feb 2025 Pg. 49	Rifaximin 20-mg/mL Oral Suspension Author(s):
Jan/Feb 2025 Pg. 50	Sertraline Hydrochloride 10-mg/mL Oral Suspension Author(s):
Jan/Feb 2025 Pg. 51	Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Author(s):
Nov/Dec 2024 Pg. 482	Benzoyl Peroxide 10% Gel Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 483	Cohen’s Rectal Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 484	Diaper Rash Cream with Miconazole Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 485	Emanuel Butt Paste Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 486	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 487	Riley Butt Cream Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 488	Sucralfate and Hyaluronic Acid Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 489	Tetracaine Hydrochloride 2% Topical Solution Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 490	Tetracaine 4% and Menthol 5% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 491	Wound Gel Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 396	Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 397	Diclofenac Sodium 1% Soft-Patch Gel Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 398	Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 399	Fluconazole 2% Topical Microemulsion Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 400	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 401	Piroxicam 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 306	Cholestyramine 6.5% Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 307	Clozapine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 308	Gabapentin 5% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 309	Ivermectin 0.8% Creme Rinse Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 310	Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 311	Milk of Magnesia Concentrate, Unflavored Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 312	Natural Head Lice Repellant Spray Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 313	Niacinamide 4% Acne Gel Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 314	Promethazine Hydrochloride 50 mg/mL in PLO Gel Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 315	Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 242	Amlodipine Besylate Veterinary Suspension Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 243	Carprofen 2.5-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 244	Diltiazem 5% in Lipoderm, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 245	Miconazole 1% Ophthalmic Solution, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 130	Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 131	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 132	Analgesic Compound Lotion, Clear Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 133	Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 134	Diclofenac Sodium 1% Soft-patch Gel Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 135	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 136	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 137	Rectal Rockets: Lidocaine 3%, Hydrocortisone 2% Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 34-43	Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism Author(s): Paoletti Jim
Jan/Feb 2024 Pg. 58	Estradiol 0.1% Vaginal Solution Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 59	Estradiol 1-mg/0.1-g Topical Cream Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 60	Estriol and Estradiol 1.25, 2.5, and 5 mg (BiEst) Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 61	Progesterone 10% Topical Cream Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 62	Progesterone 100-mg/mL Sublingual Drops Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 63	Progesterone Vaginal Suppositories (Fatty Acid Base) Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 64	Testosterone 1 mg/0.1 mL in a PLO Gel Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 67	Triple Estrogen 2.5 mg Tablet Triturates Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 446-448	Compounded "Monster Spray" for Nighttime Terrors: A Case Report Author(s): Riepl Mike
Nov/Dec 2023 Pg. 468-473	Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management Author(s): Rodriguez Franklin, Carvalho Maria, Banov Fabiana
Nov/Dec 2023 Pg. 490	Curcumin 1% Intranasal Mucoadhesive Gel Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 491	Hyaluronidase Injection Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 492	Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 493	Salicylic Acid 30% Gel Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 362-366	Compounding Metformin for Use in Functional Medicine Author(s): Desai Sarina, Thompson Tara
Sep/Oct 2023 Pg. 368-380	Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment Author(s): Riepl Mike, Kaiser Joe
Sep/Oct 2023 Pg. 397-409	Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 412	Crotamiton 10% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 414-415	Fluconazole 1% Thermoresponsive Gel Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 416	Hydrocortisone 2% in Versapro Cream Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 417	Idoxuridine 5% in Dimethyl Sulfoxide Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 418-419	Ipratropium Bromide 0.05% Nasal Spray Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 420	Nitazoxanide 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 421	Povidone Iodine Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 422-423	Silver Sulfadiazine 1% and Hydrocortisone 2% Gel Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 284-293	Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID Author(s): Riepl Mike, Kaiser Joe
Jul/Aug 2023 Pg. 316	Chlorhexidine and Cetrimide Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 317-318	Clobazam 5-mg/mL Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 319	Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 320-321	Cyclosporine Topical Gel Formulation Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 322	Dexamethasone 1 mg/mL in Oral Mix SF Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 323	Lamotrigine 1 mg/mL in SuspendIt Plus Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 324-325	Levofloxacin 0.5% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 326	Losartan Potassium 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 327	Nystatin Oromucosal Gel Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 328	Rifampin 10-mg/mL Nasal Drops Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 329	Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 330-339	Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yahoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
May/Jun 2023 Pg. 182-190	Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds Author(s): Touprong Robin, Thompson Tara, Williams LaVonn A
May/Jun 2023 Pg. 192-200	Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development Author(s): Riepl Mike, Kaiser Joe
May/Jun 2023 Pg. 232-233	Acetaminophen 500-mg/mL Rectal Solution Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 234	Doxycycline 166.7-mg/mL Oral Suspension (Veterinary) Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 235	Gentamicin 480-mg/1000-mL Bladder Irrigation Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 236	Methylene Blue 5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 237	Migraine Headache Suppositories Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 238	Nifedipine, Lidocaine, and Nitroglycerin Suppositories Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 239	Nystatin Oromucosal Viscous Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 98-107	Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment Author(s): Riepl Mike
Mar/Apr 2023 Pg. 108-112	Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Author(s): Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
Mar/Apr 2023 Pg. 142	Aminohippurate Sodium 250 mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 143	Amphotericin B 0.1% Topical Microemulsion Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 144	Aphthous Ulcer Gel Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 145	Bethanechol 0.01% in Lanolin 10% and White Petrolatum 90% Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 146	Cyclosporine Topical Microemulsion Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 147	Hypochlorous Acid 0.01% Oral Rinse Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 148	Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 149-151	Pilocarpine Hydrochloride 0.3% w/v Solution Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 152	Sacrosidase 8,500 Units Per mL Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 153	Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 160-168	Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarum K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Jan/Feb 2023 Pg. 6-10	Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE Author(s): Earlywine Kerry, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
Jan/Feb 2023 Pg. 12-21	Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants Author(s): Riepl Mike
Jan/Feb 2023 Pg. 48-49	Calculations Author(s): Stockton Shelly J
Jan/Feb 2023 Pg. 50	Acetaminophen 10 mg/mL for Rectal Use Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 51	Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 52	Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 53	Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 54	Manning's Liniment Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 55	Mayer's Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 56	Povidone Iodine 100-mg/mL Solution/Spray Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 57	Psoriasis Topical Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 58-59	Suspension Solution, Sugar Free Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 468-472	Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022 Pg. 480-488	A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Author(s): Riepl Mike
Nov/Dec 2022 Pg. 490-495	Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 508	Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 509	Curcumin 2% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 510	Diazoxide 10-mg/mL in Oral Mix SF Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 511	Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 512	Flucytosine 50 mg/mL in Oral-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 513	Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 514	Miller's Modified Mouthwash Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 515	Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding) Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 516-521	Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
Sep/Oct 2022 Pg. 364-368	A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Author(s): Riepl Mike
Sep/Oct 2022 Pg. 378-384	Compounded Medications and Probiotics for Irritable Bowel Syndrome Author(s): Narváez Katherine Rivera, Thompson Tara
Sep/Oct 2022 Pg. 400-408	Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 422	Amphotericin B 3% Otic Gel Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 423	Ascorbic acid 5% Topical Microemulsion Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 424	Chlorhexidine Diacetate 2% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 425	Clindamycin Hydrochloride 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 426	Clotrimazole 10-mg Troches Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 427	Cysteamine Hydrochloride 100 mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 428	Hydrogen Peroxide 1.5% with Sodium Fluoride 0.5-mg/mL Oral Rinse Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 429	Lansoprazole 3-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 430	Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 431	Methylcobalamin 2-mg/mL Nasal Spray Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 270-274	A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline Author(s): Riepl Mike
Jul/Aug 2022 Pg. 318	Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 319	Cetrimide Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 320	Dexamethasone 1 mg/mL in Oral Mix Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 321-322	Furosemide 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 323-324	Hydralazine Hydrochloride 10 mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 325-326	Indomethacin 1% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 327	Nystatin 250,000-unit Frozen Popsicles Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 328	Povidone Iodine 100-mg/mL Solution/Spray Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 329	Psoriasis Topical Ointment Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 189-193	A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide Author(s): Riepl Mike
May/Jun 2022 Pg. 214-217	Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 232	Alendronate Sodium 1% Topical Dental Gel Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 233	Azstarys in Ora-Blend Single Dose Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 234	Candesartan Cilexitil 1 mg/mL Syrup Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 235	Chloral Hydrate 70 mg/mL Syrup Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 236	Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 237	Clobazam 1 mg/mL in Oral-Mix Suspension Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 238	Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 239	Nitrazepam 1 mg/mL Oral Solution Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 240	Sirolimus 0.1% Ointment Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 241	Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 94-98	A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Author(s): Riepl Mike
Mar/Apr 2022 Pg. 110-115	The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report Author(s): Good Lauren, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
Mar/Apr 2022 Pg. 118-126	Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 140	Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 141	Codeine Phosphate 3 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 142	Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 143	Lorazepam 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 144	Mesalamine 100-mg/mL Suspension Enema Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 145	Naproxen 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 146	Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 147	Phenytoin 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 148	Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 149	Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 6-8	Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report Author(s): Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Jan/Feb 2022 Pg. 18-23	A Compendium of Compounding Agents and Formulations, Part 1: Melatonin Author(s): Riepl Mike
Jan/Feb 2022 Pg. 41-49	Sterile Basics: Compounding Sterile Preparations with Cyclodextrins Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 52	Aluminum Chloride 6.25% in Anhydrous Alcohol Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 53	Ascorbic Acid 10% in Anhydrous PEG ointment Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 54	Deoxyarbutin 3% Anhydrous Emulsion Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 55	Diclofenac Sodium 1%-15% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 56	Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 57	Mometasone Furoate 0.1% Lotion Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 464-467	Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports Author(s): Agbi Kelechi E, Carvalho Maria, Vieira-Banov Fabiana
Nov/Dec 2021 Pg. 468-472	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin Author(s): Riepl Mike
Nov/Dec 2021 Pg. 482-485	Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars Author(s): Harris Kylie, Wright Edward
Nov/Dec 2021 Pg. 486-489	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 12: Sorbents (Adsorbents and Absorbents) Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 500	Domperidone 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 501	Kayexalate in Lactulose Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 502	Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 503	Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 504	Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 505	Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 506	Quetiapine Fumarate 10 mg/mL in Ora-Blend Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 507	Shari's Burn Cream Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 508	Sulfadiazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 509	Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 523-527	Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution Author(s): Zaid Abdel-Naser, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
Sep/Oct 2021 Pg. 372-377	Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Author(s): Riepl Mike
Sep/Oct 2021 Pg. 412	Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 413	Cilazapril 1-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 414	Clonidine 0.01-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 415	Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 416	Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 417	Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 418	Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 419	Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 420	Sorafenib 20-mg/mL in Oil Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 421	Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 431-439	Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Jul/Aug 2021 Pg. 270-274	Growing a Compounding Practice: Successful Marketing to Underserved Populations Author(s): McKettrick Greg, Yoch Doug
Jul/Aug 2021 Pg. 282-287	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2 Author(s): Riepl Mike
Jul/Aug 2021 Pg. 320	Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 321	Atomoxetine 4-mg/mL Oral Solution/Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 322	BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 323	Budesonide 0.0.25% Mucoadhesive Gel Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 324	Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 325	Hydrocortisone 2-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 326	Moh's Paste, Modified Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 327	Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 328	Tacrolimus 0.1% Topical Microemulsion Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 329	Valsartan 4-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 197-204	A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies Author(s): Hall Essence, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal
May/Jun 2021 Pg. 232	Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 233	Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 234	Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 235	Temozolomide 10 mg/mL in Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 94-98	The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report Author(s): McKettrick Greg, Yoch Doug
Mar/Apr 2021 Pg. 100-103	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing Author(s): Riepl Mike
Mar/Apr 2021 Pg. 142	Amlodipine 1-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 143	Canine Soft Chew Base (Veterinary) Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 144	Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 145	Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 31-38	Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 40	Calculations Author(s): Stockton Shelly J
Jan/Feb 2021 Pg. 44	Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 45	Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 46	Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 47	Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 48-51	Design and Performance of an Inexpensive Water Activity Meter Author(s): Gilda Sagar S, Schober Joseph M, McPherson Timothy
Jan/Feb 2021 Pg. 52-61	Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Author(s): Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021 Pg. 82-87	Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets Author(s): Cheung Matthew, Zhao Fang, Dave Vivek S
Sep/Oct 2020 Pg. 358-364	Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients Author(s): Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol
Sep/Oct 2020 Pg. 367-369	Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent Author(s): Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna
Sep/Oct 2020 Pg. 406	Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 407	Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 278-281	Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2 Author(s): Riepl Mike
Jul/Aug 2020 Pg. 282-285	Compounding Pearls -- Wound Care: Burn Healing, Part 2 Author(s): Riepl Mike
Jul/Aug 2020 Pg. 287-295	Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Author(s): McElhiney Linda F
Jul/Aug 2020 Pg. 312	Benzonatate 50 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 313	Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 314	Doxepin Hydrochloride 5% in Cetaphil Cream Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 315	Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 316	Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 317	Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 318	Lisinopril 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 319	Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 320	Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 321	Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 182-186	Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1 Author(s): Riepl Mike
May/Jun 2020 Pg. 188-193	Compounding Pearls -- Wound Care: Burn Healing, Part 1 Author(s): Riepl Mike
May/Jun 2020 Pg. 194-197	Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
May/Jun 2020 Pg. 224	Baclofen 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 225	Dexamethasone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 226	Diphenylcyclopropenone 0.1% or 3% in Isopropranol Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 227	Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 228	Monsel's Solution, Gel, and Paste Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 229	Prednisolone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 230	Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 231	Tetracycline Hydrochloride 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 232	Ursodiol 100 mg/mL in Cod Liver Oil, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 233	Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 98-102	Compounding Pearls -- Wound Care: Base Selection Author(s): Riepl Mike
Mar/Apr 2020 Pg. 104-108	Low-dose Pilocarpine Spray to Treat Xerostomia Author(s): Zur Eyal
Mar/Apr 2020 Pg. 130	Acetazolamide 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 131	Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 132	Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 133	Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 134	Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 135	Propylthiouracil 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 136	Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 137	Terbinafine 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 138	Topiramate 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 139	Valsartan 4 mg/mL in Syrup NF Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 54	Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 55	Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 56	Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 57	Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 58	Isoniazid 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 59	LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 60	Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 61	Potassium Chloride 1 mmol/mL in Ora-Sweet SF Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 62	Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 63	Venlafaxine 15 mg/mL in Syrup Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 69-76	Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution Author(s): Marotta James C, Patel Gopesh, Carvalho Maria, Blakeney Samantha
Nov/Dec 2019 Pg. 486	Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 487	Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 488	Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 489	Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 490	Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 491	Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 492	Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 493	Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 494	Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 495	Zonisamide 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 358-364	Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report Author(s): Pope George, Daleo Charles, Batson SL
Sep/Oct 2019 Pg. 366-375	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3 Author(s): Zur Eyal
Sep/Oct 2019 Pg. 376-381	Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Author(s): Zur Eyal
Sep/Oct 2019 Pg. 406	Allopurinol 20 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 407	Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 408	Dipyridamole 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 409	Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted) Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 410	Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 411	Sorafenib Capsules for Pediatric Use Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 412	Valsartan 4 mg/mL in Vehicle for Oral Solution USP Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 413	Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 288-293	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2 Author(s): Zur Eyal
Jul/Aug 2019 Pg. 314	Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 315	Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 316	Domperidone 5 mg/mL in Oral Mix Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 317	Lorazepam 1 mg/mL in Anhydrous Organic Solvent System Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 318	Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 319	Rifampin 25 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 192-199	Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Author(s): Riepl Mike
May/Jun 2019 Pg. 200-207	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1 Author(s): Zur Eyal
May/Jun 2019 Pg. 230	Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 231	Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 232	Clopidogrel 5 mg/mL in a Sugar-Free Syrup Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 233	Flunisolide Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 234	Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 235	Methotrexate 2-mg/mL Oral Solution Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 236	Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 237	Valsartan 16-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 250-257	Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation Author(s): Rashid Mamoon, Hossain Mohammad Faisal, Nounou Mohamed, Rahman Mehbuba, Sarkar Sushanta, Adeyemo Akinola, Mullins Randy
Mar/Apr 2019 Pg. 94-104	Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Author(s): Zur Eyal
Mar/Apr 2019 Pg. 106-111	Nimodipine Compounded Oral Suspension: A True Documented Medical Need Author(s): McElhiney Linda F
Mar/Apr 2019 Pg. 113-119	Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia Author(s): Zur Eyal
Mar/Apr 2019 Pg. 146	Acetaminophen 50% Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 147	Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 148	Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 149	Dexamethasone 2 mg/g Topical Paste, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 150	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 151	Perphenazine 0.5 mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 152	Rosuvastatin 20-mg/5-mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 153	Tacrolimus 0.5 mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 167-175	Physicochemical Stability of Extemporaneously Prepared Methylcobalamin Injections in the Presence and Absence of Preservative and the Impact of Light Exposure Author(s): Ip Kendice, Banov Daniel, Bassani Gus, Morgan Latisha
Jan/Feb 2019 Pg. 14-21	The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Author(s): Williams LaVonn A
Jan/Feb 2019 Pg. 23-31	Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Author(s): Zur Eyal
Jan/Feb 2019 Pg. 52	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 53	Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 54	Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 55	Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 56	Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 57	Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 58	Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 59	Orodispersible Film Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 60	Piperacillin 10 mg/mL in 0.9% Sodium Chloride Bladder Irrigation Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 61	Thiamine Hydrochloride 100 mg/mL in SurSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 65-69	Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle Author(s): Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jan/Feb 2019 Pg. 70-76	Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Miller Valicia, Morris Tommy C, Graves Richard A
Jan/Feb 2019 Pg. 77-81	Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy Author(s): Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
Nov/Dec 2018 Pg. 446-454	Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Author(s): Zur Eyal
Nov/Dec 2018 Pg. 456-465	Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome Author(s): Riepl Mike
Nov/Dec 2018 Pg. 492	Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 493	Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 494	Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 495	Hydrocortisone 2 mg/mL in Inorpha Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 496	Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 497	Prednisone 5 mg/mL ir Oral Mix Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 498-503	Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin Author(s): Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
Nov/Dec 2018 Pg. 504-511	Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) Author(s): Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
Sep/Oct 2018 Pg. 356	PreScription: Updating Formulations Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 408	Cysteamine 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 409	Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 410	Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 411	Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 412-416	Stability of Tranexamic Acid Mouth Rinse Author(s): Donnelly Ronald F
Sep/Oct 2018 Pg. 433-439	Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding Author(s): Zhao Fang, Dave Vivek S, Mar Mazin Z, Perri Jonathan R
Jul/Aug 2018 Pg. 270-278	Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Jul/Aug 2018 Pg. 316	Anhydrous Medium-chain Triglycerides Gel Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 317	Budesonide 1-mg//10-mL Mucolox Oral Suspensions Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 318	Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 319	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 320	Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 321	Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 322	Minoxidil 50 mg/mL in Espumil Foam Base Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 323	Oseltamivir Phosphate 15 mg/mL in SyrSpend SF Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 324	Pentoxifylline 5% in Dermabase Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 325	Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 326-328	Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension Author(s): Atkins Julia R, Lull Melinda E, Decker Andrew S, Hutchinson David J
Jul/Aug 2018 Pg. 340-344	Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes Author(s): Huffman Jessica, Brown Stacy, Lewis Paul, Lawson Sarah, Ogle Amanda, Peacock Gina
May/Jun 2018 Pg. 182-188	Pitch Ointment: Applications in Scar and Wound Management Author(s): Kloesel Lawson, Carvalho Maria, Banov Fabiana
May/Jun 2018 Pg. 196-202	Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications Author(s): Agbi Kelechi E, Hover Sara, Carvalho Maria
May/Jun 2018 Pg. 232	Anhydrous Silicon Base Topical Gel Vehicle Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 233	Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 234	Dorzolamide 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 235	Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 236	Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 237	Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 238	Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 239	Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 240-246	Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals Author(s): Khokhlova Kateryna O, Zdoryk Oleksandr A
May/Jun 2018 Pg. 263	Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension Author(s):
Mar/Apr 2018 Pg. 137-143	Basics of Compounding: Compounding Microemulsions Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 146	Clonidine Hydrochloride 10 mg/mL in Inorpha Solution Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 147	Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 148	Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 149	Levodopa and Carbidopa Rectal Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 150	Prochlorperazine Edisylate 0.5% Nasal Spray Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 151	Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 152	Spironolactone 5-mg/mL in Suspendit Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 153	Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet) Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 30-39	Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients Author(s): McElhiney Linda F
Jan/Feb 2018 Pg. 50	Glutamate and Aspartate Cardioplegia Additive Solution Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 51	Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 52	Metronidazole 50 mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 53	Miconazole 10% in Recura Topical Cream Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 54	Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 55	Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 56	Ranitidine 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 57	Sodium Citrate 9% Nasal Spray for Olfactory Disorders Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 58	Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 59	Voriconazole 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 66-75	Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
Nov/Dec 2017 Pg. 481-486	Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 490	Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 491	Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 492	Fluconazole 10% in RECURA Cream Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 493	Haloperidol 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 494	Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 495	Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 496	Spironolactone 5 mg/mL in SuspendIt Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 497	Tolmetin 400-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 498	Trace Elements Injection 5 Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 499	Vancomycin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 513-517	Validation of the Technological Process of the Preparation "Milk by Vidal" Author(s): Savchenko LP, Mishchenko VA, Georgiyants VA
Sep/Oct 2017 Pg. 408	Acetylcysteine Solutions for Inhalation Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 409	Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 410	Etoposide 20-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 411	Fentanyl Citrate 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 412	Fluoxymesterone 10-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 413	Ioversol Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 414	Levocarnitine 100-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 415	Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 416	Tacrolimus 0.3-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 417	Vancomycin 50 mg/mL in Oral Syrup Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 282-289	Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Author(s): Choo Winnie
Jul/Aug 2017 Pg. 310	Calculations Author(s): Stockton Shelly J
Jul/Aug 2017 Pg. 312	Betamethasone 0.1% and Neomycin 0.6% Gel-Cream Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 313	Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 314	Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 315	Disopyramide 100-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 316	Ferrous Sulfate 30-mg Fe/mL Oral Drops Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 317	Reteplase Injection Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 318	Sertraline Hydrochloride 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 319	Tacrolimus 0.06% Ophthalmic Drops Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 320	Torsemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 321	Tranilast 8% Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 322-329	Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox) Author(s): Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
May/Jun 2017 Pg. 233	Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 234	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 235	Meloxicam 1% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 236	Ofloxacin 0.3% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 237	PVP Iodine 10% Antiseptic Cream Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 238	Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 239	Trimethoprim 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 205-211	Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
May/Jun 2017 Pg. 232	Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 146	Azathioprine 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 147	Candesartan Cilexetil 8 mg Liquid-Filled Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 148	Furosemide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 149	Ketoconazole 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 22-27	Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Author(s): Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017 Pg. 39-45	Basics of Compounding with Dilutions and Concentrates Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 60	Clindamycin 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 61	Diazoxide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 62	Infliximab 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 63	Nifedipine 0.5% Rectal Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 64	Tetracaine Hydrochloride 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 65	Zonisamide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 83-87	A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding Author(s): Rush Steven D, Vernak Charlene, Zhao Fang
Nov/Dec 2016 Pg. 495-500	Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 502	Calculations Author(s): Stockton Shelly J
Nov/Dec 2016 Pg. 504	Alendronate 70-mg/75-mL Drinkable Formulation Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 505	Bosentan 6.25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 506	Capsaicin 0.025% and Doxepin 3.3% Cream Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 507	Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 508	Erlotinib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 509	Flumazenil 0.1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 510	Imatinib 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 511	Lapatinib Ditosylate 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 512	Melatonin 2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 513	Menthol, Chloral Hydrate, and Camphor Analgesic Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 399-404	Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 406	Clobazam 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 407	Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 408	Inamrinone 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 409	Levetiracetam 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 410	Naproxen 5% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 411	Permethrin 1% Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 412	Progesterone 10% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 413	Sodium Phosphate Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 414	Tetracaine Hydrochloride 2% Topical Solution Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 415	Tromethamine Injection Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 298-305	Basics of Compounding: Compounding Films Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 318	Dolasetron Mesylate 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 319	Gatifloxacin 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 320	Mebendazole 100-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 321	Neomycin Sulfate 25-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 322	Nystatin 100,000-units Vaginal Inserts Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 323	1,2-Octanediol 5% Topical Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 324	Phytonadione 1-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 325	Plasmingen and Hyaluronate Sodium Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 326	Scopolamine Hydrobromide 0.25% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 327	Tretinoin 10-mg Oral Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 197-201	Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Author(s): Sturn Kayla M, Collin Michael
May/Jun 2016 Pg. 209-214	Basics of Compounding: Special Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 224	Calculations Author(s): Stockton Shelly J
May/Jun 2016 Pg. 226	Carboplatin 50-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 227	Cefotetan Disodium Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 228	Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 229	Dexpanthenol 5% Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 230	Indomethacin Gel Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 231	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 232	Montelukast Sodium 5-mg Fast-Dissolving Film Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 233	Pain-Away II Headache Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 234	Sodium Nitroprusside 25-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 235	Zolpidem Tartrate 5-mg and 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 257-261	Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
Mar/Apr 2016 Pg. 125-134	Basics of Compounding: Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 144	Blue Goo Anti-Itch Gel Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 145	Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 146	Medicated Polyox Bandage for Skin Ulcers Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 147	Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 46	Calculations Author(s): Stockton Shelly J
Jan/Feb 2016 Pg. 48	Aprepitant 80-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 49	Aripiprazole 10-mg Oral Dissolving Tablets Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 50	Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 51	Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 52	Mupirocin Calcium 2% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 53	Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 54	Thrombin 1,000 Units/mL Topical Solution, Sterile Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 55	Tropicamide 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 56	Vancomycin 5% and Amikacin 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 57	Voriconazole 10-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 504	Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 505	Cefepime Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 506	Cefotaxime 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 507	Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 508	Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 509	Estradiol Valerate 40-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 510	Levetiracetam 100-mg/mL Injection (Concentrate) Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 511	Memantine Hydrochloride Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 512	Mupirocin 2% Nasal Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 513	Propranolol Hydrochloride Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 367-373	Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Author(s): Guth Michael AS
Sep/Oct 2015 Pg. 404	Aminocaproic Acid 250-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 405	Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 406	Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 407	Nimodipine 3-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 408	Ofloxacin 0.3% Otic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 409	Povidone Iodine 10% Cold Sore Paint Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 410	Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 411	Vehicle for Oral Solution (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 412	Vehicle for Oral Solution, Sugar Free (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 413	Vehicle for Oral Suspension (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 414-419	Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Author(s): Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
Jul/Aug 2015 Pg. 324	Ammonium Molybdate 25-mcg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 325	Balsam Peru, Castor Oil, and Trypsin Ointment Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 326	Benzonatate 100-mg Capsules Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 327	Chloroquine Phosphate 250-mg Capsules Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 328	Cytarabine 50-mg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 329	Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 330	Oxytocin 10-units/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 331	Phytonadione 2-mg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 332	Proparacaine Hydrochloride 0.5% Ophthalmic Solution Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 333	Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg Author(s): Allen Loyd V
May/Jun 2015 Pg. 195-203	Compounded Testosterone Troches to optimize Health and the Testosterone Controversy Author(s): Guth Michael AS
May/Jun 2015 Pg. 205-211	Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls Author(s): Gonzalez Mark
May/Jun 2015 Pg. 242	Atropine Sulfate 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 243	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 244	Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 245	Phenazopyridine Hydrochloride 200-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 246	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 247	Scopolamine Hydrobromide -.4-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 252-260	Protocol of Blood Serum Eye Drops Author(s): Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
Mar/Apr 2015 Pg. 142	Acne Scrub Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 143	Aminohippurate Sodium 200-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 144	Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 145	Heparin 335-United/Gram Gel-Cream Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 146	L-Cysteine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 147	Morrhuate Sodium 5% Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 148	Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 149	Pancuronium Bromide 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 150	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 151	Trypan Blue 0.06% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 60	Atenolol 25-, 50-, or 100-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 61	Azathioprine 50-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 62	Cisplatin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 63	Daunorubicin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 64	Erythromycin 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 65	Hydralazine Hydrochloride 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 66	Hydroxychloroquine Sulfate 200-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 67	Lidocaine Hydrochloride 4% Topical Solution Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 68	Mupirocin 2% Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 69	Phentolamine Mesylate 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 444	PreScription: "Named Formulas" Database Available Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 494	Clarithromycin 250-mg or 500-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 495	Dexmedetomidine 100 mcg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 496	Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 497	Leucovorin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 498	Levocarnitine 200-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 499	Methazolamide 25-mg or 50-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 500	Methylene Blue 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 501	Methylphenidate Hydrochloride 10-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 502	Oxacillin Sodium 167-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 503	Tamsulosin Hydrochloride 0.2-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 370-377	Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report Author(s): Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Sep/Oct 2014 Pg. 382-391	Health Care in Belarus in the 19th and 20th Centuries Author(s): Tishchenko Evgenii Mikhailovich
Sep/Oct 2014 Pg. 408	Azithromycin 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 409	Bacitracin Topical Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 410	Dexpanthenol 250-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 411	Ephedrine Sulfate 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 412	Fluorescein 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 413	Indocyanine green 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 414	Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 415	Sulfamethoxazole and Trimethoprim Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 416	Sumatriptan Succinate 12-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 417	Tranexamic Acid 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 322	Atracurium Besylate 10-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 323	Barium Sulfate Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 324	Calcitriol 1-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 325	Chloramphenicol 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 326	Chlorothiazide 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 327	Choline Magnesium Trisalicylate Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 328	Denileukin Diftitox 150-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 329	Indigo Carmine Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 330	Propranolol Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 331	Zinc 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 182-188	A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Author(s): Warner Meredith, Tuder Dmitry
May/Jun 2014 Pg. 232	Atorvastatin 10-mg or 20-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 233	Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 234	Bupivacaine Hydrochloride 0.5% Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 235	Butorphanol Tartrate 10-mg/mL Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 236	Dibucaine 1% Ointment Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 237	Lidocaine Hydrochloride 1% Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 238	Methotrexate 2.5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 239	Naproxen 25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 240	Tamoxifen 10-mg or 20-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 241	Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 242-247	Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical-grade Cleanrooms Author(s): Sandle Tim
May/Jun 2014 Pg. 248-252	Investigation of Physical and Chemical Stability of an Ointment with Herbals Author(s): Zdoryk Oleksandr A, Khokhlova Kateryna O, Georgiyants Victoriya A, Vyshnevska Liliia I
May/Jun 2014 Pg. 253-255	Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Mar/Apr 2014 Pg. 112-116	Compounding Practices in Iran Author(s): Goodarzi Navid, Niknam Somayeh, Akbarzadeh Tahmineh, Gholami Kheirollah
Mar/Apr 2014 Pg. 131-134	Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 142	Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 143	Fludarabine Phosphate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 144	Mecasermin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 145	Methylprednisolone 40-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 146	Polymixin B Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 147	Rocuronium Bromide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 148	Secretin 4 mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 149	Selenium 40-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 150	Sincalide 1-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 151	Testosterone Enanthate 200-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 169-174	Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets Author(s): Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu
Jan/Feb 2014 Pg. 14-19	Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Author(s): Zur Eyal
Jan/Feb 2014 Pg. 60	Aztreonam Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 61	Bumetanide 0.25-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 62	Droperidol 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 63	Lomustine 100-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 64	Neostigmine Bromide 15-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 65	Nimodipine 30-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 66	Phenobarbital 60-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 67	Potassium Chloride 2-mEq/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 68	Procainamide Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 69	Vasopressin 20-units/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 490-495	Basics of Compounding: Basics of Compounding with Balsams Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 498	Benztropine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 499	Cefazolin 250-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 500	Ciprofloxacin 250-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 501	Cortisone Acetate 25-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 502	Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 503	Dihydroergotamine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 504	Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate) Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 505	Levothyroxine Sodium 100-mcg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 506	Metyrosine 250-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 507	Phenytoin Sodium 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 364-368	Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms Author(s): McElhiney Linda F
Sep/Oct 2013 Pg. 380-383	Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease Author(s): McElhiney Linda F
Sep/Oct 2013 Pg. 384-387	Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines Author(s): Pruitt Bobby N III
Sep/Oct 2013 Pg. 400-410	Basics of Compounding: Basics of Compounding with Tars Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 414	Acyclovir 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 415	Aminocaproic Acid 250-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 416	Clindamycin 150-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 417	Fluorouracil 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 418	Hydroxyzine Hydrochloride 25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 419	Indomethacin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 420	Mesna 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 421	Methotrexate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 422	Phenylephrine Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 423	Terbutaline Sulfate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 270-280	Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Author(s): Logomasini Mark A, Stout Richard R, Ron Marcinkoski
Jul/Aug 2013 Pg. 312-322	Basics of Compounding: Foam Dosage Forms Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 326	Acyclovir 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 327	Acyclovir 200-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 328	Allopurinol Sodium 4-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 329	Amikacin Sulfate 250-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 330	Dacarbazine 200-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 331	Ketamine 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 332	Methohexital Sodium 500-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 333	Metoprolol Tartrate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 334	Rifampin 300-mg and Isoniazid 150-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 335	Succinylcholine Chloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 228	Buffered Aspirin Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 229	Calcium Acetate 667-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 230	Estradiol 0.5-mg, 1-mg, or 2-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 231	Ethambutol 400-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 232	Isoniazid 300-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 233	Labetalol 50-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 234	Mercaptopurine 75-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 235	Naltrexone Hydrochloride 50-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 236	Prednisone 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 237	Reserpine 0.5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 247-253	Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Mar/Apr 2013 Pg. 113-123	Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Author(s): Zur Eyal
Mar/Apr 2013 Pg. 144	Adenosine 3-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 145	Alcohol Dehydrated Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 146	Betahistine 16-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 147	Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 148	Cyanocobalamin 1000-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 149	Dexrazoxane 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 150	Meropenem 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 151	Paclitaxel 6-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 152	Thiotepa 15-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 153	Verapamil Hydrochloride 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 24-27	Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil? Author(s): Wung Deanna
Jan/Feb 2013 Pg. 39-44	Adrenal Fatigue Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 64	Desmopressin 4-mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 65	Dobutamine 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 66	Granisetron 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 67	Ibuprofen 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 68	Mepivacaine Hydrochloride 1% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 69	Milrinone 0.2-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 70	Neostigmine Methylsulfate 0.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 71	Nicardipine Hydrochloride Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 72	Octreotide 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 73	Testosterone Cypionate 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 86	Errata Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 462-469	Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents Author(s): Zur Eyal
Nov/Dec 2012 Pg. 500	Aminophylline 25-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 501	Ammonium Chloride 5-mEq/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 502	Azathioprine 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 503	Copper 0.4-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 504	Dipyridamole 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 505	Dopamine Hydrochloride 80-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 506	Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 507	Papaverine Hydrochloride 30-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 508	Valproate Sodium 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 509	Vercuronium Bromide 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 364-368	Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report Author(s): McNulty Jack P, Hahn Kristian
Sep/Oct 2012 Pg. 376-380	Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol Author(s): Snyder Scott, Listecki Robert E
Sep/Oct 2012 Pg. 425	Metronidazole 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 386-393	Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Author(s): Zur Eyal
Sep/Oct 2012 Pg. 418	Doxapram Hydrochloride 20-mg/mL injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 419	Enalaprilat 1.25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 420	Esmolol Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 421	Fluconazole 2-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 422	Haloperidol 50-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 423	Meperidine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 424	Methocarbamol 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 426	Nalbuphine Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 427	Oxymorphone Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 428-430	Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Jul/Aug 2012 Pg. 270-274	A Concise Discussion of Headache Types, Part 3: Migraine Author(s): Williams LaVonn A, Allen Loyd V Jr
Jul/Aug 2012 Pg. 276-286	Compounding Prokinetic Medications for Companion Animals Author(s): Gaskins Jessica
Jul/Aug 2012 Pg. 288-293	Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Author(s): Zur Eyal
Jul/Aug 2012 Pg. 332	Betamethasone 0.6-mg/5-mL Syrup Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 333	Butorphanol Tartrate 2-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 334	Diphenhydramine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 335	Etomidate 2-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 336	Foscarnet Sodium 24-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 337	Ketorolac Tromethamine 15-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 338	Methyldopate Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 339	Ondansetron Hydrochloride 2-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 340	Sufentanil Citrate 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 341	Tobramycin 40-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 342-346	Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets Author(s): Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa'
May/Jun 2012 Pg. 190-195	I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Author(s): McElhiney Linda F
May/Jun 2012 Pg. 196-205	Burning Mouth Syndrome: A Discussion of a Complex Pathology Author(s): Zur Eyal
May/Jun 2012 Pg. 210-218	Treatment and Prevention of Insect Bites: Mosquitoes Author(s): Williams LaVonn A, Allen Loyd V Jr
May/Jun 2012 Pg. 238	Acetazolamide 100-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 239	Alfentanil 500-mcg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 240	Ascorbic Acid 250-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 241	Diltiazem Hydrochloride 5-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 242	Famotidine 10-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 243	Metoclopramide 5-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 244	Naloxone Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 245	Orphenadrine Citrate 30-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 246	Prochlorperazine 5-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 247	Ranitidine 25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 110-114	Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy Author(s): Griffee Chris, Delano Amy
Mar/Apr 2012 Pg. 162	Midazolam 5-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 163	Promethazine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 117-124	Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Author(s): Zur Eyal
Mar/Apr 2012 Pg. 125-132	A Concise Discussion of Headache Types, Part 1 Author(s): Williams LaVonn A
Mar/Apr 2012 Pg. 154	Amiodarone Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 155	Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 156	Caffeine Citrate 20-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 157	Chromium 4-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 158	Furosemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 159	Glycopyrrolate 0.2-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 160	Labetalol Hydrochloride 5-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 161	Lorazepam 4-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 77	Sodium Chloride 14.6% and 23.4% Injections Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 78	Sodium Phosphates Injection Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 79	Zinc 1-mg/mL and 5-mg/mL Injections Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 12-16	Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs Author(s): McElhiney Linda F
Jan/Feb 2012 Pg. 17-21	Vitamins: Therapy or Hype Author(s): Wynn Tom, Hoffrogge Zach
Jan/Feb 2012 Pg. 22-33	Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Author(s): Zur Eyal
Jan/Feb 2012 Pg. 34-41	Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
Jan/Feb 2012 Pg. 75	Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 76	Sodium Bicarbonate 4.2%, 5.0%, 7.5%, and 8.4% Injections Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 44-49	Case Studies of Compounded Tramadol Use in Cats Author(s): Ray Joel, Jordan Dinah, Pinelli Chris, Fackler Bethany, Boggess Donan, Clark Justin
Jan/Feb 2012 Pg. 69	Calculations Author(s): Stockton Shelly J
Jan/Feb 2012 Pg. 70	Calcium Chloride 10% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 71	Calcium Gluconate 10% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 72	Magnesium Sulfate 10% Injection (0.8 mEq/mL) Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 73	Potassium Acetate 2-mEq/mL and 4-mEq/mL Injections Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 74	Potassium Phosphates Injection Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 450-457	Compounding for Treatment of Equine Infectious Diseases: An Overview Author(s): Bramwell Bethany L
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal
Nov/Dec 2011 Pg. 464-469	Diaper Rash Relief: Common Sense Remedies and Treatments Author(s): Wiliams Kacee D, Williams LaVonn
Nov/Dec 2011 Pg. 500	Cefepime 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 501	Citric Acid 3% Mouthrinse Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 502	Dapsone 5% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 503	Lavender Oil 4% in Polyethylene Glycol Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 505	Oxandrolone 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 506	Thioguanine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 507	Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 508	Vancomycin 31-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 504	Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 509	Vancomycin 2% in Silver Sulfadiazine Cream Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 358-366	Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride Author(s): Zur Eyal
Sep/Oct 2011 Pg. 418	Carvedilol 0.625-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 419	Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 420	Lorazepam 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 421	Metoprolol Tartrate 1.25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 422	Nifedipine 1-mg/500-mg Oral Powder Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 423	Nifedipine 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 424	Rebamipide Rectal Enema Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 425	Sotalol 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 426	Sulfadiazine 100-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 427	Ursodiol 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 308-315	Transdermals: The Skin as Part of a Drug Delivery System Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 316-319	Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient Author(s): Bramwell Bethany
Jul/Aug 2011 Pg. 334	Anesthetic Nasal Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 335	Citric Acid, Potassium Citrate, and Sodium Citrate Solution Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 336	Cromolyn Sodium 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 337	Glycopyrrolate 0.5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 338	Hydrocortisone 100-mg/60-mL Retention Enema Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 339	Magnesium Sulfate Paste Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 342	Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 343	Riboflavin 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 344-349	Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate Author(s): Hergert Lisandro Y, Sperandeo Norma R, Allemandi Daniel A, Mazzieri Maria R
Jul/Aug 2011 Pg. 302-307	Treating Inner Ear Disorders with Intratympanic Drug Administration Author(s): McElhiney Linda F
Jul/Aug 2011 Pg. 340	Methylprednisolone 4-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 341	Oxandrolone 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 194-199	Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Author(s): McElhiney Linda F
May/Jun 2011 Pg. 200-203	Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Author(s): Wynn Tom, Goetsch Daniel
May/Jun 2011 Pg. 204-213	Treatment Options for Psoriasis Author(s): Williams LaVonn A, Humphreys Erica
May/Jun 2011 Pg. 214-217	Case Report: The Use of Compounded Metronidazole to Treat Clostridial and Campylobacterial Enteritis in an English Bulldog Puppy Author(s): Fellman Claire, Ray Jody, Jordan Dinah G, Hreish Viola
May/Jun 2011 Pg. 242	Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 243	Diclofenac Sodium 1% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 244	Ibuprofen 5% Topical Cream Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 246	Melatonin 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 247	Sport Body Cooler Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 248	Tannic Acid 5% Alcohol Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 249	Triamcinolone 0.1% Lotion Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 245	Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 250	Triclosan 2% Topical Cream Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 251	Wound Cleaner Solution Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 102-112	Testosterone Levels in an Aging Population: Screen, Measure, and Restore Author(s): Kells John, DollbaumCharles M
Mar/Apr 2011 Pg. 114-116	Case Report: Clindamycin Hydrochloride 1% Otic Suspension in the Management of Otitis Externa in a Canine Author(s): Rudner Shara, Pora Amanda, DeMeo Jennifer
Mar/Apr 2011 Pg. 117-122	The Relevance of the Soviet Pharmaceutical Industry and Dispensing: Dependence on Traditional Compounding Author(s): Conroy Mary Schaeffer
Mar/Apr 2011 Pg. 124-128	Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Author(s): Corsini Lindsay, Williams LaVonn A
Mar/Apr 2011 Pg. 156	Acetylcysteine 1% or 10% Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 157	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 158	Clopidogrel 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 159	Dextromethorphan Hydrobromide 15-mg Oral Film Strip Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 160	Hank's Balanced Salt Solution (Stock Solution) Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 161	Levamisole 25-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 162	Mandl's Paint Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 163	Massage Rub, Oil Free Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 164	Oral Film Strip Vehicle Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 165	Tea Tree Oil Acne Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 27-31	Goliath: Case Report on a Canine Case of Epilepsy Author(s): Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
Jan/Feb 2011 Pg. 64	Diclofenac Sodium 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 65	Hydrocortisone Acetate 1% Gel, Alcohol-Free Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 66	Ibuprofen 5% Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 67	Mandelic Acid 5% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 68	Methotrexate 30-mg/g Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 69	Piroxicam 1% Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 70	Pramoxine 1% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 71	Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 72	Terbenafine Hydrochloride Bilayer Nail Lacquer Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 73	Vancomycin Hydrochloride 25-mg/mL Solution Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 484-486	All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding Author(s): Williams KaCee D
Nov/Dec 2010 Pg. 488-491	Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin Author(s): Rudner Shara, Browne Paul
Nov/Dec 2010 Pg. 512	Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 513	Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 514	Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 517	Capsaicin 0.05% Clear Medication Stick Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 518	Glutathione 25% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 519	Gramicidin 13% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 521	Ketoprofen 2% Oral Gel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 465-471	The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women Author(s): Bramwell Bethany L
Nov/Dec 2010 Pg. 480-483	"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care Author(s): Cox Chris
Nov/Dec 2010 Pg. 515	Bromazepam 2.5-mg/mL Drops Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 516	Bromhexine Hydrochloride 0.8-mg/mL Syrup Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 520	Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 522-525	Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Author(s): Pignato Alyssa, Pankaskie Marvin, Birnie Christine
Sep/Oct 2010 Pg. 395-399	Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients Author(s): Muller George, Case Tyler, Deen Griffin L
Sep/Oct 2010 Pg. 420	Alpha-Bisabolol Mouthwash Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 422	Icy Blue Camphorated Gel Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 423	Carvedilol 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 424	Buspirone 2.5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 430-435	Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Author(s): Santoveña A, Llabrés M, Fariña JB
Sep/Oct 2010 Pg. 421	Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 425	Triclosan 0.28% Mouthwash Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 426	Rufinamide 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 427	Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 428	Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 429	Polidocanol 0.5% Wound Spray Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 270-274	Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Author(s): McElhiney Linda F
Jul/Aug 2010 Pg. 301-304	Considerations for Percutaneous Absorption Author(s): Newton Stephen J, Cook Jennifer M
Jul/Aug 2010 Pg. 332	Acyclovir with Benzocaine Lip Balm Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 333	Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 334	Amitriptyline Hydrochloride Suppositories Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 310-314	Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Author(s): Christiansen Joel, White Lyndell
Jul/Aug 2010 Pg. 335	Ampicillin 250-mg Suppository Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 336	Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 337	Buprenorphine Hydrochloride Injection Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 338	Chloroprocaine Hydrochloride Injection Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 339	Cyanocobalamin, Choline, and Niacinamide Injection Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 340	Fenoldopam Mesylate Injection Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 341	Flurbiprofen 5% Bioadhesive Gel for Gingivitis Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
May/Jun 2010 Pg. 204-206	Managing Pain with Transdermal Ketoprofen Author(s): Williams KaCee D
May/Jun 2010 Pg. 210-213	Potential Treatments for Radiation Dermatitis Author(s): Corsini Lindsay
May/Jun 2010 Pg. 215-217	Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report Author(s): Muller George
May/Jun 2010 Pg. 240	Bacitracin 10,000-Units/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 241	Carprofen 2.5-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 242	Celecoxib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 193-199	The Role of Sex Hormones on Fibromyalgia Pain Mediators Author(s): Bramwell Bethany L
May/Jun 2010 Pg. 243	Clozapine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 244	Cohen's Rectal Ointment Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 245	Cyclophosphamide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 246	Lansoprazole 3-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 247	Rifaximin 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 248	Sunitinib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 249	Voriconazole 40-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 250-256	Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration Author(s): de Villiers Melgardt M, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
Mar/Apr 2010 Pg. 94-99	Emerging Evidence for Androgen Replacement Therapy in Aging Men Author(s): Bramwell Bethany L
Mar/Apr 2010 Pg. 108-111	Coenzyme Q10 Supplementation in the Treatment of Heart Disease Author(s): Bramwell Bethany L
Mar/Apr 2010 Pg. 112-115	Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient Author(s): McElhiney Linda F
Mar/Apr 2010 Pg. 118-123	Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Author(s): McElhiney Linda F
Mar/Apr 2010 Pg. 150	Acyclovir 5% in Oral Adhesive Paste Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 151	Acyclovir 200-mg/5-mL Oral Suspension (From the Injection) Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 152	Ciclopirox 10% in Isopropyl Alcohol Nail Solution Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 153	Clotrimazole 1% Oral Adhesive Paste Author(s): Allen Loyd V Jr